| 1 |
Guideline ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males. 2009
Wang C, Nieschlag E, Swerdloff RS, Behre H, Hellstrom WJ, Gooren LJ, Kaufman JM, Legros JJ, Lunenfeld B, Morales A, Morley JE, Schulman C, Thompson IM, Weidner W, Wu FC. · Division of Endocrinology, Department of Medicine, Harbor-UCLA Medical Center and Los Angeles BioMedical Research Institute, Torrance, CA 90509, USA. · Aging Male. · Pubmed #18763169 No free full text.
This publication has no abstract.
|
| 2 |
Article [Testosterone substitution with special regard to prostate cancer] 2008
Beintker M, Behre H. · Urologische Klinik, Südharz-Krankenhaus gGmbH Nordhausen, Dr.-R.-Koch-Strasse 39, 99734 Nordhausen. · Urologe A. · Pubmed #18931991 No free full text.
Abstract: Testosterone substitution is used to treat the symptoms of low testosterone in men who do not produce enough natural testosterone. Hypogonadism is associated with a range of disease states that have significant effects on morbidity and mortality and also affect quality of life. The regular investigation of PSA, prostate, and ultrasound is necessary.
|
|
|